ATE444073T1 - Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten - Google Patents

Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Info

Publication number: ATE444073T1
Authority: AT; Austria
Prior art keywords: oxalate; degrading; preventing; related diseases; bacteria
Prior art date: 1997-05-23

Application number

AT98923673T

Other languages

English (en)

Inventor

Milton Allison

Harmeet Sidhu

Original Assignee

Oxthera Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-23

Filing date

1998-05-22

Publication date

2009-10-15

1998-05-22 Application filed by Oxthera Inc filed Critical Oxthera Inc

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE444073T1 publication Critical patent/ATE444073T1/de

Links

102000004190 Enzymes Human genes 0.000 title abstract 3
108090000790 Enzymes Proteins 0.000 title abstract 3
201000010099 disease Diseases 0.000 title abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
244000005700 microbiome Species 0.000 title 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 4
241000894006 Bacteria Species 0.000 abstract 3
210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
238000010521 absorption reaction Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT98923673T 1997-05-23 1998-05-22 Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten ATE444073T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4747397P	1997-05-23	1997-05-23
PCT/US1998/010495 WO1998052586A1 (en)	1997-05-23	1998-05-22	Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease

Publications (1)

Publication Number	Publication Date
ATE444073T1 true ATE444073T1 (de)	2009-10-15

Family

ID=21949193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98923673T ATE444073T1 (de)	1997-05-23	1998-05-22	Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Country Status (12)

Country	Link
US (1)	US6200562B1 (de)
EP (2)	EP0983076B1 (de)
JP (2)	JP4996780B2 (de)
KR (1)	KR20010012845A (de)
AT (1)	ATE444073T1 (de)
AU (1)	AU7590798A (de)
CA (1)	CA2288709C (de)
CY (1)	CY1109695T1 (de)
DE (1)	DE69841200D1 (de)
ES (1)	ES2334409T3 (de)
PT (1)	PT983076E (de)
WO (1)	WO1998052586A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355242B1 (en) *	1997-05-23	2002-03-12	Ixion Biotechnology, Inc.	Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) *	1997-05-23	2013-07-16	Oxthera, Inc.	Compositions and methods for treating or preventing oxalate-related disease
US20040120941A1 (en) *	1997-05-23	2004-06-24	Allison Milton J.	Materials and methods for treating or preventing oxalate-related disease
IT1309427B1 (it)	1999-05-28	2002-01-23	Mendes S U R L	Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
KR100956013B1 (ko)	2001-04-23	2010-05-06	샤이어 인터내쇼날 라이센싱 비.브이.	희토류 화합물을 포함하는 신장 결석 질환 치료용 약제학적 조성물
WO2003042380A2 (en) *	2001-10-05	2003-05-22	Ixion Biotechnology, Inc.	Materials and methods for reducing oxalate concentrations in fluids
US6929940B1 (en)	2002-08-20	2005-08-16	University Of Florida Research Foundation, Inc.	Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
WO2005110469A2 (en) *	2004-05-07	2005-11-24	Oxthera, Inc.	Methods and compositions for reducing oxalate concentrations
US7468182B2 (en)	2004-10-27	2008-12-23	North Carolina State University	Lactobacillus acidophilus nucleic acids and uses thereof
JP5199077B2 (ja)	2005-06-10	2013-05-15	アルタスファーマシューティカルズインコーポレイテッド	シュウ酸オキシダーゼ結晶の投与による、シュウ酸塩濃度を低下させるための方法
WO2007070052A2 (en) *	2005-12-14	2007-06-21	Oxthera, Inc.	Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) *	2005-12-16	2014-07-23	オクセラインコーポレイテッド	シュウ酸塩低減化のための組成物および方法
US8431122B2 (en)	2009-07-02	2013-04-30	Oxthera Intellectual Property Ab	Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
CN108721612A (zh)	2009-11-25	2018-11-02	凯普托杰姆有限责任公司	草酸相关疾病治疗方法和组合物
WO2015002588A1 (en)	2013-07-05	2015-01-08	Oxthera Intellectual Property Ab	Secretagogues derived from oxalobacter formigenes
WO2015083840A1 (ja)	2013-12-03	2015-06-11	協和化学工業株式会社	磁性ハイドロタルサイト類複合体およびその製造方法
CN107960105B (zh)	2015-04-02	2025-05-16	武汉康复得生物科技股份有限公司	用于降解不溶性和可溶性草酸的高效草酸降解酶
EP3468572B1 (de)	2016-06-13	2022-03-02	OxThera Intellectual Property AB	Zusammensetzungen und verfahren zur behandlung oder prävention vor erkrankungen im zusammenhang mit oxalat
US10927402B2 (en) *	2018-04-10	2021-02-23	Stem Arts Projects, Llc	Capsule for lyophilized reagent storage and delivery
WO2020018799A1 (en)	2018-07-18	2020-01-23	The University Of Chicago	Compositions comprising sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
US12421518B2 (en)	2018-12-10	2025-09-23	Tenza, Inc.	Methods and compositions for treating hyperoxaluria
US20240043791A1 (en) *	2020-12-23	2024-02-08	Massachusetts Institute Of Technology	Modified bacterium for oxalate degradation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4747397A (en)	1986-06-12	1988-05-31	Magovern George J	Flexible pad for direct myocardial tissue massage having thumb loop
US5286495A (en)	1992-05-11	1994-02-15	University Of Florida	Process for microencapsulating cells
BR9307548A (pt) *	1992-11-30	1999-06-01	Zeneca Ltd	Fragmento de dna isolado molécula recombinante célula de planta transformada oxalato decarboxilase composição processo para proteger uma planta de ácido oxálico e planta
EP0764204B1 (de) *	1994-05-18	2001-08-22	Human Genome Sciences, Inc.	HUMANE OXALYL-CoA DECARBOXYLASE
US6090628A (en)	1994-06-20	2000-07-18	University Of Florida	Materials and methods for detection of Oxalobactor formigenes
US5604111A (en) *	1994-06-20	1997-02-18	University Of Florida Research Foundation	Method and kit for detection of oxalate

1998
- 1998-05-22 JP JP55067598A patent/JP4996780B2/ja not_active Expired - Lifetime
- 1998-05-22 CA CA2288709A patent/CA2288709C/en not_active Expired - Lifetime
- 1998-05-22 WO PCT/US1998/010495 patent/WO1998052586A1/en not_active Ceased
- 1998-05-22 US US09/083,362 patent/US6200562B1/en not_active Expired - Lifetime
- 1998-05-22 AT AT98923673T patent/ATE444073T1/de active
- 1998-05-22 ES ES98923673T patent/ES2334409T3/es not_active Expired - Lifetime
- 1998-05-22 PT PT98923673T patent/PT983076E/pt unknown
- 1998-05-22 AU AU75907/98A patent/AU7590798A/en not_active Abandoned
- 1998-05-22 EP EP98923673A patent/EP0983076B1/de not_active Expired - Lifetime
- 1998-05-22 KR KR1019997010810A patent/KR20010012845A/ko not_active Ceased
- 1998-05-22 DE DE69841200T patent/DE69841200D1/de not_active Expired - Lifetime
- 1998-05-22 EP EP08168165A patent/EP2033651A1/de not_active Withdrawn
2009
- 2009-12-30 CY CY20091101351T patent/CY1109695T1/el unknown
2010
- 2010-10-22 JP JP2010237464A patent/JP2011063597A/ja active Pending

Also Published As

Publication number	Publication date
EP2033651A1 (de)	2009-03-11
WO1998052586A1 (en)	1998-11-26
KR20010012845A (ko)	2001-02-26
ES2334409T3 (es)	2010-03-09
CY1109695T1 (el)	2014-08-13
EP0983076B1 (de)	2009-09-30
CA2288709A1 (en)	1998-11-26
US6200562B1 (en)	2001-03-13
JP4996780B2 (ja)	2012-08-08
PT983076E (pt)	2010-01-05
EP0983076A1 (de)	2000-03-08
DE69841200D1 (de)	2009-11-12
CA2288709C (en)	2010-05-18
JP2001526690A (ja)	2001-12-18
JP2011063597A (ja)	2011-03-31
AU7590798A (en)	1998-12-11

Legal Events

Date

Code

Title

Description

2010-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0983076

Country of ref document: EP

Publication	Publication Date	Title
CY1109695T1 (el)	2014-08-13	Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
WO2003096990A3 (en)	2004-02-26	Protein cages for the delivery of medical imaging and therapy
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2002058684A3 (en)	2003-04-17	Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
MXPA02011656A (es)	2004-07-30	Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
BRPI0015533B8 (pt)	2021-05-25	enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação
AU1916995A (en)	1995-09-04	4-amino derivatives of mycophenolic acid with immunosuppressant activity
MY124714A (en)	2006-06-30	Enzyme treatment
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
FI920206A0 (fi)	1992-01-17	Medicinsk anvaendning, medicinskt foerfarande och preparat.
DE69620727D1 (de)	2002-05-23	Paclitaxel Prodrogen, Verfahren zur Herstellung und ihre Verwendung zur selektiven Chemotherapie
AU8296987A (en)	1988-06-30	Pharmaceutical composition comprising fluticasone propionate
TW200640944A (en)	2006-12-01	VGF polypeptides and methods of treating VGF-related disorders
NZ510153A (en)	2002-12-20	Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
WO1999056666A8 (en)	2000-08-10	The treatment of sexual dysfunction in certain patient groups
MXPA02000680A (es)	2002-07-02	Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
ATE344664T1 (de)	2006-11-15	Verbesserte methode zur eradikation von helicobacter pylori
WO2002094199A3 (en)	2003-12-24	METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
EP1083927A4 (de)	2002-01-02	Menschliches "minor vault" protein p193
WO2005056520A8 (en)	2005-09-15	Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
ATE261732T1 (de)	2004-04-15	Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
SE9700244D0 (sv)	1997-01-28	Novel antibacterial protein
IL112668A0 (en)	1995-05-26	4-amino 6-substituted mycophenolic acid and derivatives thereof, their preparation and pharmaceutical compositions containing them
AU2003227593A1 (en)	2003-10-20	New analogs of nitrobenzylthioinosine
IL112666A (en)	2000-01-31	4-Amino derivatives of 5-substituted mycophenolic acid their preparation and pharmaceutical compositions containing them